Overview: Glucose 3H Post 100g TestIntroduction: The Glucose 3H Post 100g Test measures glucose 3 hours after a 100g load to diagnose gestational diabetes, causing fatigue or thirst. Aligned with 2023 ACOG guidelines, it uses spectrophotometry for high sensitivity, aiding in pregnancy screening. This test is critical for guiding diagnosis, management, and improving outcomes in biochemistry for pregnant patients. It is the final endpoint in the 3-hour OGTT for gestational diabetes.
Other Names: Glucose 3H 100g Assay, Gestational OGTT 3H Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: The 100g OGTT for gestational diabetes was standardized in the 1980s. Spectrophotometry advancements in the 1990s improved glucose measurement accuracy.
Purpose: Diagnoses gestational diabetes, guides management, and monitors glucose levels in pregnant patients with fatigue, thirst, or excessive urination.
Test Parameters: 1. Glucose (3.0 H Post 100g)
Pretest Condition: Fasting for 10-12 hours required. Collect plasma or serum 3 hours after 100g glucose load. Report symptoms like fatigue, thirst, or polyuria, and list medications.
Specimen: 2-4 mL plasma (NaF) or 2-5 mL serum (SST). Centrifuge within 1 hour. Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, thirst, polyuria, or history of gestational diabetes. Include pregnancy stage, current medications, and family history of diabetes.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for diabetes management or monitoring.
Procedural Considerations: Uses spectrophotometry to measure glucose levels 3 hours post-100g load. Results are available in 1-2 days, enabling rapid clinical decisions. Performed in laboratories, concluding the 3-hour OGTT.
Factors Affecting Result Accuracy: Non-fasting, improper timing, hemolysis, or medications (e.g., corticosteroids) can affect results. Patient stress may alter glucose levels.
Clinical Significance: Elevated glucose levels suggest gestational diabetes, prompting dietary or insulin management. Normal levels may indicate no gestational diabetes, but clinical correlation is needed.
Specialist Consultation: Consult an obstetrician or endocrinologist for result interpretation and pregnancy management.
Additional Supporting Tests: 1-hour and 2-hour OGTT, HbA1c, fasting glucose, or ultrasound to confirm gestational diabetes and assess fetal health.
Test Limitations: Single time-point results may miss dynamic glucose changes. Results require clinical correlation and multi-point OGTT for accuracy.
References: ACOG Gestational Diabetes Guidelines, 2023; Obstetrics & Gynecology, Metzger BE, 2022.
